Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: A comparison with allotransplantation

Xenotransplantation

Volumn 18, Issue 6, 2011, Pages 328-342

  Graham, Melanie L ^a   Bellin, Melena D ^a   Papas, Klearchos K ^a   Hering, Bernhard J ^a   Schuurman, Henk Jan ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

glucose control; islet allotransplantation; islet xenotransplantation; molecular incompatibilities; non human primates; pigs

Indexed keywords

ARGININE; EFALIZUMAB; ETANERCEPT; GLUCOSE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN C; RAPAMYCIN; TACROLIMUS; TEPLIZUMAB; THYMOCYTE ANTIBODY;

ADULT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE DEFICIENCY; INSULIN RELEASE; MACACA; MALE; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SWINE; XENOTRANSPLANTATION;

ADULT; ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIET; FEMALE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA; MALE; MIDDLE AGED; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 83755206323     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2011.00676.x     Document Type: Review

References (53)

1. Shapiro AM, Ricordi C, Hering BJ, et al., International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318-1330. (Pubitemid 44465460)
2. Alejandro R, Barton FB, Hering BJ, Wease S,. Collaborative Islet Transplant Registry Investigators 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008; 86: 1783-1788.
3. Shapiro AM, Lakey JR, Ryan EA, et al., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238. (Pubitemid 30490390)
4. Hering BJ, Wijkstrom M, Graham ML, et al., Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303. (Pubitemid 43355076)
5. Van Der Windt DJ, Bottino R, Casu A, et al., Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
6. Cardona K, Korbutt GS, Milas Z, et al., Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306. (Pubitemid 43355077)
7. Thompson P, Cardona K, Russell M, et al., CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957.
8. Hammer C, Thein E,. Physiological aspects of xenotransplantation, 2001. Xenotransplantation 2002; 9: 303-308.
9. Hammer C,. Physiological obstacles after xenotransplantation. Ann NY Acad Sci 1998; 862: 19-27. (Pubitemid 29044008)
10. Hammer C, Linke R, Wagner F, Diefenbeck M,. Organs from animals for man. Int Arch Allergy Immunol 1998; 116: 5-21. (Pubitemid 28211952)
11. Cooper DKC, Casu A,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009; 16: 229-238.
12. Casu A, Bottino R, Balamurugan AN, et al., Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120-129. (Pubitemid 350197988)
13. Alejandro R, Cutfield RG, Shienvold FL, et al., Natural history of intrahepatic canine islet cell autografts. J Clin Invest 1986; 78: 1339-1348. (Pubitemid 17181574)
14. Keymeulen B, Gillard P, Mathieu C, et al., Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. PNAS 2006; 103: 17444-17449. (Pubitemid 44788988)
15. The Clinical Islet Transplantation (CIT) Consortium. http://www. citisletstudy.org/ [accessed 1 July 2011].
16. Yang EJ, Kerver JM, Park YK, Kayitsinga J, Allison DB, Song WO,. Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III). Am J Clin Nutr 2003; 77: 1426-1433. (Pubitemid 39655275)
17. Bansal-Pakala P, Pahuja A, Hennessey E, Graham M, Hering BJ, Blazar BR,. Ex vivo expanded Treg therapy promotes long-term islet allograft survival in a non-human primate model. Am J Transplant 2011; 11 (Suppl s2): 209.
18. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW,. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420. (Pubitemid 18096377)
19. Papas KK, Pisania A, Wu H, Weir GC, Colton CK,. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng 2007; 98: 1071-1082. (Pubitemid 350205583)
20. DAIT, NIAID, NIH. SOP Document No. 3104, A03, Revision 3, Effective Date 25 October 2010. Purified human pancreatic islets, glucose stimulated insulin release determination by ELISA. http://www.isletstudy.org/CITDocs/SOP%203104, %20A03,%20v03,%20GSIR%20Elisa,%20October%2025,%202010.pdf [accessed 1 July 2011].
21. Stevens CE, Hume ID,. Comparative Physiology of the Vertebrate Digestive System. Cambridge UK: Cambridge University Press, 1995.
22. Miller ER, Ullrey DE,. The pig as a model for human nutrition. Annu Rev Nutr 1987; 7: 361-382.
23. Patterson JK, Lei XG, Miller DD,. The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exp Biol Med (Maywood) 2008; 233: 651-664.
24. Austin GL, Ogden LG, Hill JO,. Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971-2006. Am J Clin Nutr 2011; 93: 836-843.
25. Coote SW, Wolfe-Coote S,. The Laboratory Primate. Amsterdam: Elsevier Academic Press, 2005.
26. Nutrient Requirements of Swine. Washington DC: National Academy Press, 1998.
27. Hocquette JF, Ortigues-Marty I, Pethick D, Herpin P, Fernandez X,. Nutritional and hormonal regulation of energy metabolism in skeletal muscles of meat-producing animals. Livest Prod Sci 1998; 56: 115-143. (Pubitemid 128409952)
28. Willmann S, Edginton AN, Dressman JB,. Development and validation of a physiology-based model for the prediction of oral absorption in monkeys. Pharm Res 2007; 24: 1275-1282. (Pubitemid 46880982)
29. Wijkstrom M, Kenyon NS, Kirchhof N, et al., Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720. Transplantation 2004; 77: 827-835. (Pubitemid 38436818)
30. Kenyon NS, Wijkstrom M, Kirchhof N, et al., Development of a non-human primate marginal mass model and preliminary demonstration of enhanced metabolic control in allogeneic islet recipients treated with TP10 and immunosuppressed with basiliximab, RAD001, and FTY720. Am J Transplant 2002; 2 (Suppl S3): 362.
31. Cardona K, Milas Z, Strobert E, et al., Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268. (Pubitemid 47347856)
32. Graham ML, Mutch LA, Rieke EF, et al., Refining the high-dose streptozotocin-induced diabetic nonhuman primate model: an evaluation of risk factors and outcomes. Exp Biol Med 2011; 236: 1218-1230.
33. Tigno XT, Gerzanich G, Hansen BC,. Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 2004; 59: 1081-1088. (Pubitemid 40024272)
34. Marigliano M, Casu A, Bertera S, Trucco M, Bottino R,. Hemoglobin A1C Percentage in nonhuman primates: a useful tool to monitor diabetes before and after porcine pancreatic islet xenotransplantation. J Transplant 2011; 2011: 965605. Epub 2011 Apr 17.
35. Bertuzzi F, Berra C, Socci C, et al., Glucagon improves insulin secretion from pig islets in vitro. J Endocrinol 1995; 147: 87-93.
36. Steiner DJ, Kim A, Miller K, Hara M,. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2010; 2: 135-145.
37. C ollaborative I slet T ransplant R egistry (CITR). Sixth Annual Report, November 1, 2009. [accessed 1 July 2011], 2011.
38. Sutherland DE, Gruessner AC, Carlson AM, et al., Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 2008; 86: 1799-1802.
39. Papas KK, Bellin M, Sutherland DE, et al., Viable islet dose based on oxygen consumption rate predicts clinical islet autotransplant outcome. Transplantation 2010; 90: 137.
40. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC,. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110. (Pubitemid 36042113)
41. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A,. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001; 50 (Suppl 1): S154-S159. (Pubitemid 32148243)
42. Weir GC, Bonner-Weir S,. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53 (Suppl 3): S16-S21. (Pubitemid 39564517)
43. Luzi L, Perseghin G, Brendel MD, et al., Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001; 50: 277-282. (Pubitemid 32127283)
44. Luzi L, Hering BJ, Socci C, et al., Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 2611-2618. (Pubitemid 26187349)
45. Ryan EA, Imes S, Wallace C,. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004; 27: 1028-1032. (Pubitemid 38579760)
46. Weng J, Li Y, Xu W, et al., Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008; 371: 1753-1760. (Pubitemid 351697950)
47. Leahy JL, Hirsch IB, Peterson KA, Schneider D,. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab 2010; 95: 4206-4216.
48. Kroon E, Martinson LA, Kadoya K, et al., Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008; 26: 443-452. (Pubitemid 351501814)
49. Tuch BE, Monk RS,. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 1991; 51: 1156-1160.
50. Castaing M, Péault B, Basmaciogullari A, Casal I, Czernichow P, Scharfmann R,. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 2001; 44: 2066-2076. (Pubitemid 33124053)
51. Yang H, Wright JR Jr,. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 2002; 143: 2491-2495. (Pubitemid 34701310)
52. Hayek A, Beattie GM,. Experimental transplantation of human fetal and adult pancreatic islets. J Clin Endocrinol Metab 1997; 82: 2471-2475. (Pubitemid 27337859)
53. Hecht G, Eventov-Friedman S, Rosen C, et al., Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 2009; 106: 8659-8664.